Mimedx (MDXG) Intangibles (2010 - 2026)
Mimedx (MDXG) reported Intangibles of $13.1 million for Q1 2026, up 18.79% on a YoY basis from $11.1 million in Q1 2025, and down 7.19% sequentially from $14.2 million in Q4 2025.
Mimedx (MDXG) Intangibles (2010 - 2026) Analysis & Trends
Mimedx (MDXG) has 17 years of Intangibles data on file, last reported at $13.1 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles rose 18.79% year-over-year to $13.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.1 million (up 18.79% YoY), and the FY2025 full-year result was $14.2 million, up 21.78% from the prior year.
- Intangibles slipped to $13.1 million in Q1 2026, from $14.2 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $14.2 million in Q4 2025 to a low of $5.0 million in Q3 2022.
- A 5-year average of $8.9 million and a median of $11.1 million in 2025 frame the typical range for Intangibles.
- Across the five-year window, Intangibles surged 121.15% in 2024 and retreated 11.86% in 2025, its largest moves.
- Tracing MDXG's Intangibles over 5 years: stood at $5.9 million in 2022, then declined by 10.17% to $5.3 million in 2023, then soared by 121.15% to $11.6 million in 2024, then grew by 21.78% to $14.2 million in 2025, then fell by 7.19% to $13.1 million in 2026.
- Business Quant data shows MDXG's Intangibles at $13.1 million in Q1 2026, $14.2 million in Q4 2025, and $11.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | 13.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.14 Mn |
| Dec 31, 2025 | 14.16 Mn |
| Sep 30, 2025 | 11.15 Mn |
| Jun 30, 2025 | 12.03 Mn |
| Mar 31, 2025 | 11.06 Mn |
| Dec 31, 2024 | 11.63 Mn |
| Sep 30, 2024 | 11.20 Mn |
| Jun 30, 2024 | 12.05 Mn |
| Mar 31, 2024 | 12.55 Mn |
| Dec 31, 2023 | 5.26 Mn |
| Sep 30, 2023 | 5.40 Mn |
| Jun 30, 2023 | 5.57 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 5.14 Mn |
| Mar 31, 2022 | 5.27 Mn |
| Dec 31, 2021 | 5.38 Mn |
| Sep 30, 2021 | 5.62 Mn |
| Jun 30, 2021 | 5.75 Mn |